← Back to headlines
Basilea Pharmaceutica Reports GAAP EPS of CHF 2.13 and Revenue of CHF 118.99M
Basilea Pharmaceutica AG announced its GAAP EPS of CHF 2.13 and revenue of CHF 118.99 million.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
